BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23324327)

  • 1. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome.
    Toscano MG; Anderson P; Muñoz P; Lucena G; Cobo M; Benabdellah K; Gregory PD; Holmes MC; Martin F
    Dis Model Mech; 2013 Mar; 6(2):544-54. PubMed ID: 23324327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
    Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
    Front Immunol; 2021; 12():607836. PubMed ID: 33717090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of WASp Enhances Hematopoietic and Megakaryocytic Differentiation in a Human Embryonic Stem Cell Model.
    Toscano MG; Muñoz P; Sánchez-Gilabert A; Cobo M; Benabdellah K; Anderson P; Ramos-Mejía V; Real PJ; Neth O; Molinos-Quintana A; Gregory PD; Holmes MC; Martin F
    Mol Ther; 2016 Feb; 24(2):342-353. PubMed ID: 26502776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The open conformation of WASP regulates its nuclear localization and gene transcription in myeloid cells.
    Looi CY; Sasahara Y; Watanabe Y; Satoh M; Hakozaki I; Uchiyama M; Wong WF; Du W; Uchiyama T; Kumaki S; Tsuchiya S; Kure S
    Int Immunol; 2014 Jun; 26(6):341-52. PubMed ID: 24402308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
    Prete F; Catucci M; Labrada M; Gobessi S; Castiello MC; Bonomi E; Aiuti A; Vermi W; Cancrini C; Metin A; Hambleton S; Bredius R; Notarangelo LD; van der Burg M; Kalinke U; Villa A; Benvenuti F
    J Exp Med; 2013 Feb; 210(2):355-74. PubMed ID: 23337808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryocyte-specific Profilin1-deficiency alters microtubule stability and causes a Wiskott-Aldrich syndrome-like platelet defect.
    Bender M; Stritt S; Nurden P; van Eeuwijk JM; Zieger B; Kentouche K; Schulze H; Morbach H; Stegner D; Heinze KG; Dütting S; Gupta S; Witke W; Falet H; Fischer A; Hartwig JH; Nieswandt B
    Nat Commun; 2014 Sep; 5():4746. PubMed ID: 25187265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wiskott-Aldrich syndrome.
    Ochs HD; Thrasher AJ
    J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions.
    Ishihara D; Dovas A; Park H; Isaac BM; Cox D
    PLoS One; 2012; 7(1):e30033. PubMed ID: 22279563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
    Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
    J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
    Blundell MP; Worth A; Bouma G; Thrasher AJ
    Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
    Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
    J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
    Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
    J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WASP: a key immunological multitasker.
    Thrasher AJ; Burns SO
    Nat Rev Immunol; 2010 Mar; 10(3):182-92. PubMed ID: 20182458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.
    Castiello MC; Bosticardo M; Pala F; Catucci M; Chamberlain N; van Zelm MC; Driessen GJ; Pac M; Bernatowska E; Scaramuzza S; Aiuti A; Sauer AV; Traggiai E; Meffre E; Villa A; van der Burg M
    J Autoimmun; 2014 May; 50(100):42-50. PubMed ID: 24369837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation.
    Watanabe Y; Sasahara Y; Ramesh N; Massaad MJ; Yeng Looi C; Kumaki S; Kure S; Geha RS; Tsuchiya S
    J Allergy Clin Immunol; 2013 Sep; 132(3):648-655.e1. PubMed ID: 23684068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
    Adriani M; Aoki J; Horai R; Thornton AM; Konno A; Kirby M; Anderson SM; Siegel RM; Candotti F; Schwartzberg PL
    Clin Immunol; 2007 Jul; 124(1):41-8. PubMed ID: 17512803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome.
    Taylor MD; Sadhukhan S; Kottangada P; Ramgopal A; Sarkar K; D'Silva S; Selvakumar A; Candotti F; Vyas YM
    Sci Transl Med; 2010 Jun; 2(37):37ra44. PubMed ID: 20574068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.